Journal profile · Clinical Neurology

LANCET NEUROLOGY

ISSN 1474-4422 · eISSN 1474-4465 · Lancet Publishing Group · ENGLAND · Monthly · Founded 2002

LANCET NEUROLOGY: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 51.38; hybrid open access; APC about USD 7,280; median 128 days to acceptance (60 articles, last 24 months); community-reported acceptance: very hard; 254 articles in 2025; indexed in SCIE and Scopus.

Impact factor51.38Latest value listed by LetPub
CAS zoneZone 1 · Medicine2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Medicine
Review time128 daysMedian, submission to acceptance · 60 articles, last 24 months · PubMed
APCUSD 7,280Hybrid journal: charged only for open-access articles
AcceptanceVery hardCommunity average
Articles per year2542025 · OpenAlex count

Scope

Aims, scope and focus

LANCET NEUROLOGY is published by Lancet Publishing Group and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Acute Ischemic Stroke Management, Parkinson's Disease Mechanisms and Treatments and Multiple Sclerosis Research Studies, together about 22.9% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)

The Lancet Neurology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. As the global leader in clinical neurology, the journal delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of clinical neurology.

From the journal's Aims & Scope

Research area (LetPub): Clinical Neurology

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Acute Ischemic Stroke ManagementMedicine8.6%
  2. Parkinson's Disease Mechanisms and TreatmentsMedicine7.9%
  3. Multiple Sclerosis Research StudiesMedicine6.5%
  4. Dementia and Cognitive Impairment ResearchMedicine6%
  5. Neurological disorders and treatmentsMedicine5.9%
  6. Alzheimer's disease research and treatmentsMedicine5.6%
  7. Epilepsy research and treatmentMedicine5.4%
  8. Amyotrophic Lateral Sclerosis ResearchMedicine4.7%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorClinical NeurologyZone 1

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorClinical NeurologyZone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorClinical NeurologyZone 1

Top journal: yesReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
51.38LetPub ·
Impact factor (publisher)
54.6Publisher website ·
CiteScore 2026-06
75LetPub ·
CiteScore (publisher)
75Publisher website ·
SJR 2026-06
12.44LetPub ·
SNIP 2026-06
15.38LetPub ·
h-index
259LetPub ·
h-index
459OpenAlex ·
i10-index
2,776OpenAlex ·
2-year mean citedness
16.52OpenAlex ·
Self-citation rate
1.1%LetPub ·
Share of gold OA articles
16.97%LetPub ·

Volume

Articles per year
71LetPub ·

Articles by year OpenAlex count · 7,358 in total · the current year is incomplete

YearArticlesOpen accessCitations
202621641287
2025254833,239
20243221059,558
202327012412,259
20222799917,452
202125611926,422

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

128 daysMedian, submission to acceptance · P25–P75 35 days – 214 days

Acceptance to online
median 48 days (8 articles)
Submission to online
median 138 days
Sample
60 articles with submission and acceptance dates (565 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
Very hardLetPub ·
Submission to first decision
5 daysPublisher website ·
First decision after review
39 daysPublisher website ·
Submission to acceptance
43 daysPublisher website ·
Acceptance to publication
47 daysPublisher website ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 7,280 / EUR 6,810 / GBP 5,830 / JPY 902,940——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Lancet Publishing Group
Country or region
ENGLAND
Language
English
Frequency
Monthly
Founded
2002
ISSN
1474-4422
Electronic ISSN
1474-4465
Official links

FAQ

Frequently asked questions about LANCET NEUROLOGY

What CAS zone is LANCET NEUROLOGY in?

In the 2025 upgraded edition of the CAS Journal Ranking, LANCET NEUROLOGY is in Zone 1 of Medicine, and in Zone 1 of the minor category Clinical Neurology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of LANCET NEUROLOGY?

The latest impact factor listed by LetPub is 51.38; CiteScore 75, h-index 459.

How long does peer review take at LANCET NEUROLOGY?

Based on the dates recorded on 60 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 128 days (interquartile range 35–214 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Very hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index LANCET NEUROLOGY?

According to LetPub and DOAJ records, LANCET NEUROLOGY is indexed in SCIE and Scopus.

Is LANCET NEUROLOGY open access, and what is the APC?

LANCET NEUROLOGY is a hybrid journal. For open-access publication: APC about USD 7,280.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .